Zymergen Inc.

Sell-side

Exclusive Financial Advisor, October 2022

Sale to Ginkgo Bioworks Holdings, Inc. (NYSE: DNA)

Zymergen Inc. (NASDAQ: ZY) and ("the company") is a biotech company that designs and produces bio-advantaged molecules, microbes and materials for diverse end markets. The company leverages its proprietary synthetic biofacturing platform with a best-in-class metagenomics database and a modular laboratory automation offering enabling production of highly differentiated products at scale and reduced cost.

More Like This

Sep 2022

Sale to Pajaro Valley Healthcare District Project

Exclusive Investment Banker

View Details >
Sep 2022

Sale to House of HR

Financial Advisor

View Details >
Sep 2022

Sale of the Operating Business to Aiutanda GmbH and Real Estate Portfolio to Carestone Group GmbH

Financial Advisor

View Details >